Johnson & Johnson buy PapaSmurf
Start price
16.10.22
/
50%
€170.02
Target price
16.10.23
-
Performance (%)
-14.68%
End price
06.03.23
€145.06
Summary
This prediction ended on 06.03.23 with a price of €145.06. The price of Johnson & Johnson has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.68%. Dividends of €2.16 are taken into consideration when calculating the performance. PapaSmurf has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Johnson & Johnson | 2.134% | 2.134% | -6.813% |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% |